Brian Dorsey insider trades: ARS Pharmaceuticals (SPRY) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Brian reports to the SEC
Open-market buys and sales
19 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 13, 2025 | SPRY | ↓ Sell | 21,828 | $8.71 | $190K | Direct | Nov 14, 2025 (1d) |
| Dec 12, 2024 | SPRY | ↓ Sell | 40,000 | $12.35 | $494K | Direct | Dec 13, 2024 (1d) |
| Aug 20, 2024 | SPRY | ↓ Sell | 50,000 | $15.00 | $750K | Direct | Aug 21, 2024 (1d) |
| Aug 13, 2024 | SPRY | ↓ Sell | 30,000 | $13.00 | $390K | Direct | Aug 15, 2024 (2d) |
| Dec 29, 2014 | APRI | ↑ Buy | 10,000 | $1.05 | $10K | Direct | Dec 30, 2014 (1d) |
| Jan 3, 2012 | SOMX | ↓ Sell | 9,000 | $0.48 | $4K | Direct | Jan 4, 2012 (1d) |
| Dec 1, 2010 | SOMX | ↓ Sell | 8,468 | $2.68 | $23K | Direct | Dec 3, 2010 (2d) |
| Sep 1, 2010 | SOMX | ↓ Sell | 3,000 | $4.27 | $13K | Direct | Sep 3, 2010 (2d) |
| Aug 25, 2010 | SOMX | ↓ Sell | 5,000 | $4.99 | $25K | Direct | Aug 27, 2010 (2d) |
| Aug 10, 2010 | SOMX | ↓ Sell | 3,000 | $3.99 | $12K | Direct | Aug 13, 2010 (3d) |
| Jul 15, 2010 | SOMX | ↓ Sell | 3,000 | $3.99 | $12K | Direct | Jul 16, 2010 (1d) |
| Jun 24, 2010 | SOMX | ↓ Sell | 9,000 | $4.48 | $40K | Direct | Jun 25, 2010 (1d) |
| Mar 18, 2010 | SOMX | ↓ Sell | 70,500 | $6.70 | $472K | Direct | Mar 22, 2010 (4d) |
| Mar 1, 2010 | SOMX | ↓ Sell | 29,000 | $4.00 | $116K | Direct | Mar 2, 2010 (1d) |
| Feb 5, 2010 | SOMX | ↓ Sell | 20,712 | $3.06 | $63K | Direct | Feb 9, 2010 (4d) |
| Dec 31, 2009 | SOMX | ↓ Sell | 5,000 | $1.07 | $5K | Direct | Jan 5, 2010 (5d) |
| May 1, 2009 | SOMX | ↓ Sell | 1,000 | $0.37 | $370 | Direct | May 4, 2009 (3d) |
| May 31, 2007 | SOMX | ↓ Sell | 1,500 | $15.00 | $23K | Direct | Jun 4, 2007 (4d) |
| Apr 27, 2007 | SOMX | ↓ Sell | 5,000 | $15.64 | $78K | Direct | Apr 27, 2007 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SPRY insiders
Open-market trades in the last 12 months
About Brian Dorsey's insider trades
Brian Dorsey is Chief Operating Officer at ARS Pharmaceuticals (SPRY). Since Apr 27, 2007, Brian has reported 1 open-market purchase worth $10K and 18 sales worth $2.7M on SEC Form 4. In the last 12 months: 1 sale ($190K).
Their filings also include grants and awards (28 filings), option exercises (15 filings), shares withheld for taxes (6 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SPRY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.